New applications to cancer research are emerging with advances in mass spectrometry-based diagnostics.These advances are revolutionizing molecular medicine.
Peroxisome proliferator-activated receptors (PPAR) are members of the nuclear hormone receptor family involved in the expression of genes involved in severa